RecallDepth
Class III Terminated

Buprenorphine and Naloxone Sublingual Tablets, 2 mg/0.5 mg 30 tablets per bottle, Rx only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5720-56

Company
Teva Pharmaceuticals Usa
Recall Initiated
June 29, 2017
Posted
July 26, 2017
Recall Number
D-0983-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
25264 bottles
Firm Location
North Wales, PA, United States

Reason for Recall

Failed Impurities/Degradation Specifications: out of specification test results for related compounds largest unknown impurity.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: 30227613A, 30227614A, 30227615A, EXP 6/2017; 30228559A, 30228560A, EXP 9/2017; 3000123, EXP 7/2018

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class III Drug recalls